Search Results - "Byrne, Christopher J"

Refine Results
  1. 1

    Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis by Gurun, Marc, Brennan, Paul, Handjiev, Sava, Khatib, Aseil, Leith, Damien, Dillon, John F, Byrne, Christopher J

    Published in PloS one (16-04-2024)
    “…Metabolic dysfunction associated steatotic liver disease (MASLD) increases the risk of incident chronic kidney disease (CKD). However, the relative risk of CKD…”
    Get full text
    Journal Article
  2. 2

    'It was like coming back from the clouds': a qualitative analysis of the lived experience of overdose consequent to drug use among a cohort of people who use drugs in Scotland by Byrne, Christopher J, Sani, Fabio, Flynn, Teresa, Malaguti, Amy

    Published in Harm reduction journal (07-06-2024)
    “…Globally, non-fatal overdose (NFOD) rates consequent to drug use, typically opioids, continue increasing at a startling rate. Existing quantitative research…”
    Get full text
    Journal Article
  3. 3

    Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison by Byrne, Christopher J, Malaguti, Amy, Inglis, Sarah Karen, Dillon, John F

    Published in BMJ open (10-04-2023)
    “…ObjectivesHepatitis C virus (HCV) poses a global public health threat. Prisons are a focus of prevention efforts due to high infection burdens. Expedition of…”
    Get full text
    Journal Article
  4. 4

    Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT by Lee, Jeremy, Byrne, Christopher J., Brennan, Paul N., MacPherson, Iain, Dow, Eleanor, Dillon, John F.

    Published in Annals of hepatology (01-03-2024)
    “…Early diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD), especially with advanced fibrosis, is crucial due to the increased risk of…”
    Get full text
    Journal Article
  5. 5

    Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis by Byrne, Christopher J, Sani, Fabio, Thain, Donna, Fletcher, Emma H, Malaguti, Amy

    Published in Harm reduction journal (15-04-2024)
    “…Psychological and social status, and environmental context, may mediate the likelihood of experiencing overdose subsequent to illicit drug use. The aim of this…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Long-term risk factors for developing Barrett’s oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study by Byrne, Christopher J, Brennan, Paul, Carberry, James, Cotton, James, Dillon, John F

    Published in BMJ open gastroenterology (22-03-2024)
    “…Background and aimsSeveral characteristics are known to affect the risk of Barrett’s oesophagus (BO) in the general population, with symptomatic…”
    Get full text
    Journal Article
  8. 8

    Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland by Malaguti, Amy, Byrne, Christopher J., Sani, Fabio, Power, Kevin, Eriksen, Ann, Dillon, John F.

    Published in Behavioral medicine (Washington, D.C.) (02-04-2024)
    “…The risk of Hepatitis C Virus (HCV) acquisition among People Who Inject Drugs (PWID) remains high when injecting risk behavior within networks endures. Several…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials by Abraham, Ned S, Byrne, Christopher J, Young, Jane M, Solomon, Michael J

    Published in Journal of clinical epidemiology (01-03-2010)
    “…Abstract Objective To compare the results of meta-analysis of nonrandomized comparative studies (NRCSs) of a surgical procedure with that of randomized…”
    Get full text
    Journal Article
  11. 11

    Real‐world outcomes of rapid regional hepatitis C virus treatment scale‐up among people who inject drugs in Tayside, Scotland by Byrne, Christopher J., Beer, Lewis, Inglis, Sarah K., Robinson, Emma, Radley, Andrew, Goldberg, David J., Hickman, Matthew, Hutchinson, Sharon, Dillon, John F.

    Published in Alimentary pharmacology & therapeutics (01-03-2022)
    “…Summary Background In 2017, Tayside, a region in the East of Scotland, rapidly scaled‐up Hepatitis C Virus (HCV) outreach and treatment among People Who Inject…”
    Get full text
    Journal Article
  12. 12

    A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease by Ivancovsky Wajcman, Dana, Byrne, Christopher J, Dillon, John F, Brennan, Paul N, Villota-Rivas, Marcela, Younossi, Zobair M, Allen, Alina M, Crespo, Javier, Gerber, Lynn H, Lazarus, Jeffrey V

    Published in Hepatology (Baltimore, Md.) (15-08-2024)
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) management guidelines have been published worldwide; we aimed to summarize, categorize and…”
    Get full text
    Journal Article
  13. 13

    A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland by Byrne, Christopher J, Radley, Andrew, Fletcher, Emma, Thain, Donna, Stephens, Brian P, Dillon, John F

    Published in The International journal of drug policy (01-10-2023)
    “…•Existing nurse-led blood-borne virus pathways were adapted to provide a sustained holistic healthcare package for people who use drugs in Tayside,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis by Hayes, Mark J., Beavon, Emma, Traeger, Michael W., Dillon, John F., Radley, Andrew, Nielsen, Suzanne, Byrne, Christopher J., Richmond, Jacqui, Higgs, Peter, Hellard, Margaret E., Doyle, Joseph S.

    Published in EClinicalMedicine (01-03-2024)
    “…The World Health Organization seeks to eliminate viral hepatitis as a public health threat by 2030. This review and meta-analysis aims to evaluate the…”
    Get full text
    Journal Article
  16. 16

    Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis by Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne

    Published in PloS one (01-01-2024)
    “…Background and aimsMetabolic dysfunction associated steatotic liver disease (MASLD) increases the risk of incident chronic kidney disease (CKD). However, the…”
    Get full text
    Journal Article
  17. 17

    Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysisResearch in context by Mark J. Hayes, Emma Beavon, Michael W. Traeger, John F. Dillon, Andrew Radley, Suzanne Nielsen, Christopher J. Byrne, Jacqui Richmond, Peter Higgs, Margaret E. Hellard, Joseph S. Doyle

    Published in EClinicalMedicine (01-03-2024)
    “…Background: The World Health Organization seeks to eliminate viral hepatitis as a public health threat by 2030. This review and meta-analysis aims to evaluate…”
    Get full text
    Journal Article
  18. 18

    REPORTING FOREIGN TRANSFERS: RECENT DEVELOPMENTS AFFECT U.S. DONEES by Byrne, Christopher J

    Published in The CPA journal (1975) (01-01-2000)
    “…In recent years, US tax law has been significantly modified to track the flow of funds received by US persons from non-US sources. Specifically, US persons…”
    Get full text
    Journal Article
  19. 19

    ESTATE AND GIFT TAX PLANNING FOR THE INTERNATIONAL EXECUTIVE by Byrne, Christopher J

    Published in The CPA journal (1975) (01-11-1999)
    “…In today's global marketplace, many executives are now finding themselves on international career paths. The executive may be working for a foreign corporation…”
    Get full text
    Journal Article
  20. 20

    Comparative study of five blood cardioplegia systems by Byrne, C J, Bednarski, A J, Beckley, P D

    Published in The Journal of extra-corporeal technology (01-12-1994)
    “…Five blood cardioplegia delivery systems (Gish Straight Shot, Sorin BCD Advanced, Avecor MYOtherm, Baxter-Bentley HE-30, and Baxter-Bentley HE-30 Gold) were…”
    Get more information
    Journal Article